immatics biotechnologies GmbH (4A3) — Cash Flow Reinvestment Rate
immatics biotechnologies GmbH (4A3) has a Cash Flow Reinvestment Rate of 0.87x as of December 2023, reinvesting €69.03 Million (capex €9.29 Million plus investments €59.74 Million) from operating cash flow of €79.08 Million. Check earnings quality score of immatics biotechnologies GmbH to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
immatics biotechnologies GmbH Cash Flow Reinvestment Rate (2018–2023)
Historical reinvestment intensity for immatics biotechnologies GmbH across 6 annual periods. Explore immatics biotechnologies GmbH cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for immatics biotechnologies GmbH (2018–2023)
Year-by-year capital reinvestment analysis for immatics biotechnologies GmbH. For live market cap and broader valuation context, see 4A3 company net worth.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 3.42x | €62.34 Million | €18.23 Million | €30.96 Million | ▲ +63.6% |
| 2022 | 2.09x | €209.37 Million | €100.13 Million | €5.74 Million | ▲ +1046.8% |
| 2021 | 0.18x | €18.26 Million | €100.13 Million | €5.11 Million | ▲ +15.2% |
| 2020 | 0.16x | €15.85 Million | €100.13 Million | €7.42 Million | ▲ +121.7% |
| 2019 | 0.07x | €5.07 Million | €70.97 Million | €2.14 Million | ▼ -89.1% |
| 2018 | 0.65x | €13.53 Million | €20.68 Million | €429.00K | — |